Testing better treatments for severe histoplasmosis
Treatments studied
Part of Infections clinical trials.
This trial tests different combinations of medicines for people hospitalized with a serious fungal infection called histoplasmosis. The goal is to find the most effective way to treat the infection and help patients recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the hospital with suspected or confirmed histoplasmosis.
- You have a positive test for histoplasmosis (antigen, culture, or microscope).
- You or a family member can give permission for the study.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have kidney problems, certain heart rhythm issues, or other conditions that would make the study medicines unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether a high-dose form of amphotericin B made in tiny fat particles (liposomal amphotericin B) is safer and more effective for treating widespread Histoplasmosis in adults with HIV. It may help people who have a serious, whole-body infection caused by Histoplasma.
This trial is testing new treatments for cryptococcal meningitis, a serious brain infection, in people living with HIV. It aims to find the best way to treat this infection with fewer side effects.
This study tests whether a combination of two antifungal drugs works well for treating talaromycosis, a serious fungal infection common in people with HIV. The goal is to find a more convenient and effective treatment.
This trial tests a single high dose of a potent antifungal medicine (liposomal amphotericin B) combined with a modern HIV treatment (B/F/TAF) for people with HIV who have a serious fungal infection called talaromycosis. The goal is to see if this short, powerful treatment works well and is safe.
This trial tests a combination of two antifungal medications (liposomal amphotericin B and posaconazole or isavuconazole) to treat a serious fungal infection called mucormycosis in people with blood cancers like leukemia or lymphoma. The goal is to see if this combination is safe and works well.
This trial tests antifungal drugs in people with a rare but serious fungal infection in the lungs called mucormycosis. It aims to find which treatment works best and is safest for patients.
Hear when a new Histoplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.